/EINPresswire.com/ -- ORLANDO, FL -- (Marketwired) -- 05/13/16 -- CEOLIVE, Inc., a provider of in-depth video interviews with public company CEOs (www.ceolive.tv), announced today that a new interview with Todd Davis, CEO of Endexx Corp. (EDXC), a provider of innovative hemp derived phyto-nutrients and nutritional products which trades under ticker EDXC, is now available on their website.

The video interview can be viewed at the following link:

http://ceolive.tv/edxc-m3hub-legitimizes-patient-transactions-for-medical-marijuana/

About Endexx Corp.
ENDEXX Corp. (EDXC) is a provider of innovative medical marijuana management and technology solutions. It offers m3Hub, a platform that manages patient concentric data and incorporates best patient privacy practices through verification, privacy, legal, and transparent controls, as well as legitimizes the entire transaction process on behalf of patients.

Disclaimer

CEOLIVE content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in CEOLIVE content and productions, or other investor relations materials and presentations are subject to change. Neither CEOLIVE nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. CEOLIVE is not a registered broker-dealer or registered investment advisor. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov or other applicable regulatory authorities.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.